Your trusted destination for CME, CPD & Medical Education across the Middle East.
Hamad Medical Corporation
Dr. Noora Shahbeck is a pioneering clinical and metabolic geneticist with extensive expertise in human genetics, clinical biochemistry, and inherited neurometabolic disorders. After completing her foundational medical training at Arabian Gulf University and her Arab Board certification in pediatrics, she undertook specialized fellowship training in metabolic medicine at Heidelberg University in Germany, supplemented by advanced clinical attachments focusing on newborn screening, mitochondrial disorders, and lysosomal storage diseases at premier European centers.
In her current leadership capacity as Acting Chair of the Medical Genetics Department at Hamad Medical Corporation (HMC) in Qatar, Dr. Shahbeck manages complex pediatric and adult metabolic caseloads, directs multidisciplinary rare disease (MDT) teams, and plays an integral role in national genomic initiatives such as the Qatar Genome Project. Her specialized clinical and research repertoire encompasses the diagnostic evaluation of inborn errors of metabolism,homocystinuria and vitamin B12 deficiencies, emergency stabilization of acute metabolic decompensation, and translating genomic sequencing discoveries into routine clinical practice.
Beyond her institutional and clinical duties, Dr. Shahbeck is a founding member of the Middle East Metabolic Genetic Group (MEMG) and a prolific author of peer-reviewed literature addressing regional genetic epidemiology. At flagship academic congresses such as the 6th Annual MENA Metabolic & Genetic Conference (MGC2026), her expert lectures and panel contributions provide attending clinicians, biochemical geneticists, and laboratory specialists with cutting-edge,practical frameworks to improve early detection and patient outcomes across the region.

Maarefah Management
Maarefah Management